T1	Intervention 506 557	status of BRAF c.1799T>A (p.V600E) mutation and MSI
T2	Intervention 622 742	adjuvant chemotherapy trial [5-fluorouracil and leucovorin (FU/LV) vs. irinotecan (CPT11), FU and LV (IFL); CALGB 89803]
T3	Intervention 865 886	adjuvant chemotherapy
T4	Intervention 1490 1510	IFL versus FU/LV arm
T5	Intervention 1645 1656	FU/LV alone
T6	Intervention 1599 1602	IFL
